1 |
Cubero, S., Aleixos, N., Molto, E., Gomez-Sanchis, J. and Blasco, J. 2011. Advances in machine vision applications for automatic inspection and quality evaluation of fruits and vegetables. Food Bioproc. Technol. 4:487-504.
DOI
|
2 |
Park, J., Lee, G. M., Kim, D., Park, D. H. and Oh, C.-S. 2018. Characterization of the lytic bacteriophage phiEaP-8 effective against both Erwinia amylovora and Erwinia pyrifoliae causing severe diseases in apple and pear. Plant Pathol. J. 34:445-450.
DOI
|
3 |
Pereira, C., Moreirinha, C., Teles, L., Rocha, R., Calado, R., Romalde, J. L., Nunes, M. L. and Almeida, A. 2017. Application of phage therapy during bivalve depuration improves Escherichia coli decontamination. Food Microbiol. 61:102-112.
DOI
|
4 |
Ranjan, R., Rani, A., Metwally, A., McGee, H. S. and Perkins, D. L. 2016. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem. Biophys. Res. Commun. 469:967-977.
DOI
|
5 |
Smith, P. and Schuster, M. 2019. Public goods and cheating in microbes. Curr. Biol. 29: R442-R447.
DOI
|
6 |
Tolaas, A. G. 1915. A bacterial disease of cultivated mushrooms. Phytopathology 5:51-54.
|
7 |
Wang, X., Wei, Z., Yang, K., Wang, J., Jousset, A., Xu, Y., Shen, Q. and Friman, V.-P. 2019. Phage combination therapies for bacterial wilt disease in tomato. Nat. Biotechnol. 37:1513-1520.
DOI
|
8 |
Yen, M., Cairns, L. S. and Camilli, A. 2017. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. Nat. Commun. 8:14187.
|
9 |
Pedreschi, R., Hertog, M., Lilley, K. S. and Nicolai, B. 2010. Proteomics for the food industry: opportunities and challenges. Crit. Rev. Food Sci. Nutr. 50:680-692.
DOI
|
10 |
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G. and Que, Y. A. 2017. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J. Infect. Dis. 215:703-712.
|
11 |
Yun, Y.-B., Park, S.-W., Cha, J.-S. and Kim, Y.-K. 2013. Biological characterization of various strains of Pseudomonas tolaasii that causes brown blotch disease. J. Korean Soc. Appl. Biol. Chem. 56:41-45.
DOI
|
12 |
Yun, Y.-B., Han, J.-H. and Kim, Y.-K. 2018a. Characterization of phage-resistant strains derived from Pseudomonas tolaasii 6264, which causes brown blotch disease. J. Microbiol. Biotechnol. 28:2064-2070.
DOI
|
13 |
Yun, Y.-B. and Kim, Y.-K. 2020. Molecular analysis of peptide toxins secreted by various Pseudomonas tolaasii strains. J. Appl. Biol. Chem. 63:387-392 (in Korean).
DOI
|
14 |
Yun, Y.-B., Lee, H.-J. and Kim, Y.-K. 2018b. Increase in antifungal activity by the combination of tolaasin and its analogue peptides. J. Appl. Biol. Chem. 61:69-73.
DOI
|
15 |
Geels, F. P. 1995. Pseudomonas tolaasii control by kasugamycin in cultivated mushrooms (Agaricus bisporus) J. Appl. Bacteriol. 79:38-42.
DOI
|
16 |
Dong, Z., Xing, S., Liu, J., Tang, X., Ruan, L., Sun, M., Tong, Y. and Peng, D. 2018. Isolation and characterization of a novel phage Xoo-sp2 that infects Xanthomonas oryzae pv. oryzae. J. Gen. Virol. 99:1453-1462.
DOI
|
17 |
Fernandez, L., Gutierrez, D., Rodriguez, A. and Garcia, P. 2018. Application of bacteriophages in the agro-food sector: a long way toward approval. Front. Cell Infect. Microbiol. 8:296.
|
18 |
Food and Drug Administration. 2006. Food additives permitted for direct addition to food for human consumption; bacteriophage preparation. Fed. Regist. 71:47729-47732.
|
19 |
Godfrey, S. A., Harrow, S. A., Marshall, J. W. and Klena, J. D. 2001. Characterization by 16S rRNA sequence analysis of pseudomonads causing blotch disease of cultivated Agaricus bisporus. Appl. Environ. Microbiol. 67:4316-4323.
DOI
|
20 |
Geels, F. P., van Griensven, L. J. L. D. and Rutjens, A. J. 1991. Chlorine dioxide and the control of bacterial blotch on mushrooms, caused by Pseudomonas tolaasii. In: Science and cultivation of edible fungi, ed. by M. J. Maher, pp. 437-442. Balkema, Rotterdam, Netherlands.
|
21 |
Gundogdu, A., Bolkvadze, D. and Kilic, H. 2016. In vitro effectiveness of commercial bacteriophage cocktails on diverse extended-spectrum beta-lactamase producing Escherichia coli strains. Front. Microbiol. 7:1761.
|
22 |
Hibbing, M. E., Fuqua, C., Parsek, M. R. and Peterson, S. B. 2010. Bacterial competition: surviving and thriving in the microbial jungle. Nat. Rev. Microbiol. 8:15-25.
DOI
|
23 |
Khalifa, L., Shlezinger, M., Beyth, S., Houri-Haddad, Y., Coppenhagen-Glazer, S., Beyth, N. and Hazan, R. 2016. Phage therapy against Enterococcus faecalis in dental root canals. J. Oral Microbiol. 8:32157.
|
24 |
Hyman, P. and Abedon, S. T. 2010. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 70:217-248.
DOI
|
25 |
Iacobellis, N. S. and Lo Cantore, P. 1998. Recenti acquisizioni sul determinismo della batteriosi del cardoncello (Pleurotus eryngii). Agricoltura Ricerca 176:51-54 (in Italian).
|
26 |
Lee, C.-J., Yoo, Y.-M., Han, J.-Y., Jhune, C.-S., Cheong, J.-C., Moon, J.-W., Suh, J.-S., Han, H.-S. and Cha, J.-S. 2014. Pseudomonas azotoformans HC5 effective in antagonistic of mushrooms brown blotch disease caused by Pseudomonas tolaasii. Korean J. Mycol. 42:219-224 (in Korean).
DOI
|
27 |
Lee, H. I., Lee, S. D., Park, K. S., Kim, Y. K. and Cha, J. S. 1997. Pathogenicity of bacterial isolates from brown blotchdiseased oyster mushrooms in Chungcheongbuk-do. J. Agric. Sci. Chungbuk Nat. Univ. 14:121-132 (in Korean).
|
28 |
Munsch, P., Oliver, J. M. and Houdeau, G. 1991. Experimental control of bacterial blotch by bacteriophages. In: Science and cultivation of edible fungi, ed. by M. J. Maher, pp. 389-396. Balkema, Rotterdam, Netherlands.
|
29 |
Lee, H.-J., Yun, Y.-B., Huh, J.-H. and Kim, Y.-K. 2017. Suppression of green mold disease on oak mushroom cultivation by antifungal peptides. J. Appl. Biol. Chem. 60:149-153 (in Korean).
DOI
|
30 |
Ministry of Agriculture, Food and Rural Affairs. 2021. Special crop production statistics 2019. URL https://lib.mafra.go.kr/skyblueimage/5729.pdf [20 August 2022].
|
31 |
Abedon, S. T. 2016. Commentary: phage therapy of Staphylococcal chronic osteomyelitis in experimental animal model. Front. Microbiol. 7:1251.
|
32 |
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S. and Brussow, H. 2004. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob. Agents Chemother. 48:2558-2569.
DOI
|
33 |
Abdelrhim, A. S., Ahmad, A. A., Omar, M. O. A., Hammad, A. M. M. and Huang, Q. 2021. A new Streptomyces scabies-infecting bacteriophage from Egypt with promising biocontrol traits. Arch. Microbiol. 203:4233-4242.
DOI
|